# Amphix Bio, Inc. — Form D

Amphix Bio, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-19. The offering totals $12.5M, of which $10.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-12-19
- Form: D
- Accession: 0002101704-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.5M
- Amount sold: $10.3M
- Remaining: $2.2M
- Investors: 9
- Date of first sale: 2025-12-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-567448

## Issuer

- Name: Amphix Bio, Inc.
- CIK: 0002101704
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 400 N. ABERDEEN ST., CHICAGO, IL, 60642
- Phone: 720-840-7327

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| John Potocsnak | Director | Chicago, IL |
| Nicholas Sather | Director | Chicago, IL |
| Samuel Stupp | Director | Chicago, IL |
| Stephen R Wilson | Director | Chicago, IL |
| Kok-Wai Wong | Director | Chicago, IL |
| Nicholas Sather | Executive Officer | Chicago, IL |
| Samuel Stupp | Executive Officer | Chicago, IL |

## More

- [CIK 2101704 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2101704&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002101704-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.